SHSE:600529 (China)
Â
Class A
Â¥
28.71
(+0.81%)
Apr 25
Business Description
Shandong Pharmaceutical Glass Co Ltd
NAICS : 327215
SIC : 3231
ISIN : CNE000001BG9
Share Class Description:
SHSE:600529: Class ACompare
Compare
Traded in other countries / regions
600529.China IPO Date
2002-06-03Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1566.76 | |||||
| Equity-to-Asset | 0.81 | |||||
| Interest Coverage | 121.97 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 8.16 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.2 | |||||
| 3-Year EBITDA Growth Rate | 8.4 | |||||
| 3-Year EPS without NRI Growth Rate | 6.4 | |||||
| 3-Year FCF Growth Rate | 121.9 | |||||
| 3-Year Book Growth Rate | 16.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.26 | |||||
| 9-Day RSI | 36.7 | |||||
| 14-Day RSI | 42.92 | |||||
| 6-1 Month Momentum % | 7.2 | |||||
| 12-1 Month Momentum % | 18.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.25 | |||||
| Quick Ratio | 2.67 | |||||
| Cash Ratio | 1.62 | |||||
| Days Inventory | 113.94 | |||||
| Days Sales Outstanding | 71.2 | |||||
| Days Payable | 137.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.05 | |||||
| Dividend Payout Ratio | 0.23 | |||||
| Forward Dividend Yield % | 1.05 | |||||
| 5-Year Yield-on-Cost % | 1.96 | |||||
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | 1.08 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.76 | |||||
| Operating Margin % | 19.28 | |||||
| Net Margin % | 16.56 | |||||
| FCF Margin % | 9.15 | |||||
| ROE % | 11.24 | |||||
| ROA % | 9.04 | |||||
| ROIC % | 16.26 | |||||
| ROC (Joel Greenblatt) % | 28 | |||||
| ROCE % | 13.35 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23 | |||||
| PE Ratio without NRI | 22.18 | |||||
| Shiller PE Ratio | 38.71 | |||||
| Price-to-Owner-Earnings | 83.58 | |||||
| PEG Ratio | 1.67 | |||||
| PS Ratio | 3.81 | |||||
| PB Ratio | 2.46 | |||||
| Price-to-Tangible-Book | 2.54 | |||||
| Price-to-Free-Cash-Flow | 41.67 | |||||
| Price-to-Operating-Cash-Flow | 16.83 | |||||
| EV-to-EBIT | 16.13 | |||||
| EV-to-EBITDA | 16.13 | |||||
| EV-to-Revenue | 3.2 | |||||
| EV-to-FCF | 34.98 | |||||
| Price-to-Projected-FCF | 2.91 | |||||
| Price-to-DCF (Earnings Based) | 0.79 | |||||
| Price-to-DCF (FCF Based) | 1.33 | |||||
| Price-to-Median-PS-Value | 1.12 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.09 | |||||
| Price-to-Graham-Number | 1.58 | |||||
| Price-to-Net-Current-Asset-Value | 4.88 | |||||
| Price-to-Net-Cash | 18.52 | |||||
| Earnings Yield (Greenblatt) % | 6.2 | |||||
| FCF Yield % | 2.4 | |||||
| Forward Rate of Return (Yacktman) % | 10.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Pharmaceutical Glass Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,013.064 | ||
| EPS (TTM) (Â¥) | 1.25 | ||
| Beta | 1.06 | ||
| Volatility % | 22.13 | ||
| 14-Day RSI | 42.92 | ||
| 14-Day ATR (Â¥) | 1.03513 | ||
| 20-Day SMA (Â¥) | 30.3885 | ||
| 12-1 Month Momentum % | 18.63 | ||
| 52-Week Range (Â¥) | 21.61 - 32.33 | ||
| Shares Outstanding (Mil) | 663.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Pharmaceutical Glass Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Pharmaceutical Glass Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Pharmaceutical Glass Co Ltd Frequently Asked Questions
What is Shandong Pharmaceutical Glass Co Ltd(SHSE:600529)'s stock price today?
The current price of SHSE:600529 is ¥28.71. The 52 week high of SHSE:600529 is ¥32.33 and 52 week low is ¥21.61.
When is next earnings date of Shandong Pharmaceutical Glass Co Ltd(SHSE:600529)?
The next earnings date of Shandong Pharmaceutical Glass Co Ltd(SHSE:600529) is .
Does Shandong Pharmaceutical Glass Co Ltd(SHSE:600529) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Pharmaceutical Glass Co Ltd(SHSE:600529) is 1.05% (As of Today), Highest Dividend Payout Ratio of Shandong Pharmaceutical Glass Co Ltd(SHSE:600529) was 0.32. The lowest was 0.21. And the median was 0.28. The  Forward Dividend Yield % of Shandong Pharmaceutical Glass Co Ltd(SHSE:600529) is 1.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers